For the quarter ending 2025-09-30.
| Income Statement | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenues | 0 | 0 | - | - |
| Selling, general and administrative expenses | 207,845 | 187,373 | 653,423.5* | 326,018 |
| Research and development | 25,334 | 80,983 | 158,528.5* | 65,885 |
| Total operating expenses | 233,179 | 268,356 | 811,952 | 391,903 |
| Loss from operations | -233,179 | -268,356 | -811,952* | -391,903 |
| Interest expense | - | - | 8,080.5* | - |
| Loss (gain) on settlement of debt | - | - | -58,945* | 115,085 |
| Interest expense - related party | - | - | - | 19,231 |
| Interest expense | 30,684 | 25,100 | - | 7,613 |
| Interest expense - related party | 21,731 | 21,731 | 19,231* | - |
| Gain (loss) on settlement of debt | 0 | 0 | - | - |
| Total other income (expenses) | -52,415 | -46,831 | -86,256.5* | 88,241 |
| Net (loss) | - | - | - | -303,662 |
| Net loss | -285,594 | -315,187 | -898,208.5 | - |
| Diluted EPS | 0 | 0 | -0.004 | - |
| Diluted Average Shares | 257,809,759 | 257,139,815 | 248,187,166 | 248,614,744 |
United Health Products, Inc. (UEEC)
United Health Products, Inc. (UEEC)